Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, August 28 to Friday, September 1, 2023) and click each link to read and watch anything you may have missed.
1.) Changing the RSV prevention landscape
From a virus that had no treatment options, to one that may be prevented in two different modalities, clinicians are hoping to see a reduction in respiratory syncytial virus (RSV) incidence rates, starting this fall.
2.) FDA approves multiple lisdexamfetamine dimesylate generics for ADHD in children
Patients 6 years and up with ADHD now have alternate options for prescription lisdexamfetamine dimesylate (Vyvanse; Takeda Pharmaceuticals USA Inc), after the FDA-approval of multiple generic options.
3.) Original mRNA vaccines helped protect children against COVID-19-associated ED visits
According to a recent Morbidity and Mortality Weekly Report, the original COVID-19 monovalent and bivalent vaccines helped reduce emergency department or urgent care encounters for children aged 6 months to 5 years.
4.) How are gut microbiomes and pediatric neurological, cognitive conditions being linked?
Rob Knight, PhD, Wolfe Endowed Chair in Microbiome Science at Rady Children's Hospital-San Diego, professor of pediatrics, UCSD, explains how links between gut microbiomes and cognitive and neurological conditions are being researched and what could be ahead for these associations in children.
5.) Stigmas, structure are the biggest school days challenges of diabetes management
A new report examined the challenges of diabetes management during the school years from the perspective of the daily social and institutional challenges children face.